Related Experiment Video
Updated: Sep 21, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy
Elaheh Malakan Rad1, Sara Momtazmanesh2
1Department of Pediatric Cardiology, Children's Medical Center (Pediatric Center of Excellence), Tehran University of Medical Sciences, Tehran, Iran. erad@tums.ac.ir.
Insights
This case study highlights a rare instance of silent COVID-19 myocarditis in a child, leading to dilated cardiomyopathy and new-onset hypertension. Early cardiac evaluation and blood pressure monitoring are crucial for children with COVID-19.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Cardiovascular Imaging
Background:
- COVID-19 myocarditis affects 7-28% of hospitalized patients, potentially leading to fulminant myocarditis or dilated cardiomyopathy.
- While dilated cardiomyopathy post-COVID-19 has been noted in children, silent cases progressing to this condition are unreported.
- Newly developed hypertension post-COVID-19 is documented in adults, but not previously in children.
Purpose of the Study:
- To report the first case of silent COVID-19 myocarditis progressing to dilated cardiomyopathy and newly developed systemic hypertension in a pediatric patient.
- To emphasize the importance of cardiac evaluation and blood pressure monitoring in children following SARS-CoV-2 infection.
Main Methods:
- A 3-year-old boy with respiratory distress was evaluated after a history of SARS-CoV-2 infection.
- Echocardiography revealed severe left ventricular systolic dysfunction consistent with dilated cardiomyopathy.
- Cardiac magnetic resonance imaging confirmed myocarditis; treatment with inotropic support showed no improvement.
Main Results:
- The patient presented with symptoms indicative of dilated cardiomyopathy and myocarditis.
- Despite initial treatment, left ventricular function did not improve, necessitating transfer for advanced cardiac support.
- The case demonstrates a progression from silent COVID-19 myocarditis to dilated cardiomyopathy and new-onset hypertension.
Conclusions:
- COVID-19 can induce silent myocarditis, potentially progressing to dilated cardiomyopathy and systemic hypertension in children.
- Mandatory cardiac assessment and blood pressure measurement are recommended for all children with COVID-19.
- Cardiac MRI, strain imaging (apical rocking, prestretch-rebound stretch), and M-mode echocardiography (septal flash) are valuable diagnostic and prognostic tools.
Background:
COVID-19 myocarditis occurs in 7-28% of patients admitted in the hospital with or without multisystem inflammatory syndrome. It may present as fulminant myocarditis. Dilated cardiomyopathy as a sequela of COVID-19 myocarditis has been reported in the pediatric population. However, to date, no case of silent COVID-19 myocarditis progressing to dilated cardiomyopathy has been reported in children. Furthermore, although newly developed hypertension as a sequela of COVID-19 infection has been reported in adults, there is no report of newly developed COVID-induced hypertension in children. We report a 3-year-old boy with silent COVID-19 myocarditis progressing to dilated cardiomyopathy and newly developed systemic hypertension.
Case Presentation:
A 3-year-old boy was referred to the emergency department because of respiratory distress. The parents gave a history of SARS-CoV-2 infection in the child 5 months ago that was manifested as fever and cough, for which he was treated as an outpatient. Echocardiographic examination revealed a severe decrease in left ventricular systolic function in favor of dilated cardiomyopathy. Cardiac magnetic resonance imaging established the diagnosis of myocarditis. The patient left ventricular systolic function did not improve after 2 weeks of intravenous inotropic support. Therefore, the child was transferred to another tertiary center with extracorporeal membrane oxygenation and pediatric cardiac transplantation facilities.
Conclusions:
COVID-19 can induce silent myocarditis with progression to dilated cardiomyopathy and newly developed systemic hypertension. Thus, a thorough examination of the heart and measurement of blood pressure are mandatory in every child with COVID-19 infection. Cardiac MR is an indispensable tool in the diagnosis, follow-up, and prognostication of COVID-19 myocarditis. Moreover, four-chamber speckle tracking strain imaging showed apical rocking in all the four heart chambers in this child with opposite direction in the failed left ventricle compared with other cardiac chambers. Lastly, the presence of septal flash on M-mode echocardiography, apical rocking and prestretch-rebound stretch patterns on longitudinal strain imaging of the failed left ventricle in this child may be of predictive value for response to cardiac resynchronization therapy.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension II: Pathophysiology
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis III: Medical Management

